Issuance of $6,500,000,000 aggregate principal amount of senior notes Overview On November 5, 2026, HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “Parent Guarantor”), completed the public offering of (i) $500,000,000 aggregate principal amount of its 5.200% Senior Notes due 2028 (the “2028 Notes”), (ii) $300,000,000 aggregate principal amount of its Floating Rate Senior Notes due 2028 (the “Floating Rate Notes”), (iii) $1,000,000,000 aggregate principal amount of its 5.350% Senior Notes due 2029 (the “2029 Notes”), (iv) $1,250,000,000 aggregate principal amount of its 5.500% Senior Notes due 2031 (the “2031 Notes”), (v) $1,200,000,000 aggregate principal amount of its 5.750% Senior Notes due 2033 (the “2033 Notes”), (vi) $1,500,000,000 aggregate principal amount of its 6.000% Senior Notes due 2036 (the “2036 Notes”) and (vii) $750,000,000 aggregate principal amount of its 6.500% Senior Notes due 2056 (the “2056 Notes” and, together with the 2028 Notes, the Floating Rate Notes, the 2029 Notes, the 2031 Notes, the 2033 Notes and the 2036 Notes, the “Notes”), each guaranteed on a senior unsecured basis by the Parent Guarantor.
|
HCA Healthcare, Inc. is a health care services company that operates a network of hospitals and outpatient facilities in the United States and England. The company manages general acute care hospitals, behavioral hospitals, and rehabilitation hospitals, alongside freestanding ambulatory surgery centers, endoscopy centers, emergency care facilities, urgent care clinics, diagnostic centers, and physician practices. Services include inpatient and outpatient medical and surgical care, cardiology, oncology, neurosurgery, orthopedics, obstetrics, and mental health treatment. The company also provides home health, hospice, and physical therapy services. HCA Healthcare commenced operations in 1968 through its predecessors and was incorporated in 2010. Summarised from the company's own disclosures, fiscal year ended Feb 2026 |
Industry Medical Care Facilities | Homepage hcahealthcare.com |
| Sector Healthcare | IR page investor.hcahealthcare.com | |
|
Tags
acute care, behavioral health, ambulatory surgery, emergency care, diagnostic imaging, rehabilitation, home health, hospice, physician practices, oncology, cardiology
|
Press page — |
Metrics
| Valuation | |
|---|---|
| Market cap | $ 106.665B |
| Market cap (USD) | $ 106.665B |
| P/E | 16.79 |
| PEG | 2.65 |
| P/BV | -13.21 |
| P/S | 1.36 |
| P/OCF | 9.55 |
| P/FCF | 17.86 |
| Dividend yield | 0.61% |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | -112.6% |
| ROI | 16.8% |
| ROIC | 23.4% |
| Profit margin | 9.0% |
| Growth | |
|---|---|
| Revenue growing | Yes |
| Profits growing | Yes |
| Revenue up 3y | Yes |
| Revenue up 5y | Yes |
| Earnings growth 3y (net profit CAGR) | 6.3% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | Yes |
| Buying back stock | Yes |
| Diluting (TTM) | No |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 24 |
| Quality score | 31.6% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 | FY 2001 | FY 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 75.6B | 70.603B | 64.968B | 60.233B | 58.752B | 51.533B | 51.336B | 46.677B | — | — | — | 36.918B | 34.182B | 33.013B | 29.682B | 28.035B | 30.052B | 28.374B | 26.858B | 25.477B | 24.455B | 23.502B | 21.808B | 19.729B | 17.953B | 16.67B |
| Net profit | 6.784B | 5.76B | 5.242B | 5.643B | 6.956B | 3.754B | 3.505B | 3.787B | 2.216B | 2.89B | 2.129B | 1.875B | 1.556B | 1.605B | 2.465B | 1.207B | 1.054B | 673M | 874M | 1.036B | 1.424B | 1.246B | 1.332B | 833M | 886M | 219M |
| Free cash flow | 7.692B | 5.639B | 4.687B | 4.127B | 5.382B | 6.397B | 3.444B | 3.188B | 2.411B | 2.893B | 2.359B | 2.272B | 1.737B | 2.313B | 2.254B | 1.76B | 1.43B | 197M | -48M | -20M | 1.567B | 1.536B | 328M | 1.032B | 43M | 392M |
| Figure | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 | FY 2001 | FY 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share price | 466.86 | 300.15 | 270.68 | 239.96 | 256.92 | 164.46 | 147.81 | 124.45 | 87.84 | 74.02 | 67.63 | 73.39 | 47.71 | 30.17 | 21.2 | — | — | — | — | 43.21 | — | 44.05 | — | — | — | — |
| Price performance 12m | 0.56 | 0.11 | 0.13 | -0.07 | 0.56 | 0.11 | 0.19 | 0.42 | 0.19 | 0.09 | -0.08 | 0.54 | 0.58 | 0.42 | — | — | — | — | — | — | — | — | — | — | — | — |
Filed figures
Lines the statements and their notes report beside the headline figures, read from the filings' XBRL as filed (no restatement applied), with figures computed from one filing's own lines. Cash-flow lines carry their cash direction: an outflow is negative. Each period links to its filing; a figure's period, report date and tag are in its tooltip.
| Figure | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet detail | ||||||||||
| Trade receivables (USD) | 5.83B | 6.5B | 6.79B | 7.38B | 7.05B | 8.1B | 8.89B | 9.96B | 10.8B | 10.9B |
| ↳ YoY growth | -1.1% | +11.6% | +4.4% | +8.7% | -4.5% | +14.8% | +9.8% | +12.0% | +8.0% | +1.1% |
| ↳ 5y CAGR | +5.1% | +6.8% | +5.4% | +5.3% | +3.7% | +6.8% | +6.5% | +8.0% | +7.8% | +9.0% |
| Borrowings, current (USD) | 216M | 200M | 788M | 145M | 209M | 237M | 370M | 2.42B | 4.7B | 4.89B |
| Borrowings, non-current (USD) | 31.2B | 32.9B | 32B | 33.6B | 30.8B | 34.3B | 37.7B | 37.2B | 38.3B | 41.6B |
| Lease liabilities (USD) | — | — | — | 2.41B | 2.67B | 2.87B | 2.83B | 2.97B | 2.99B | 2.96B |
| Cash and deposits (USD) | 646M | 732M | 502M | 621M | 1.79B | 1.45B | 908M | 935M | 1.93B | 1.04B |
| Right-of-use assets (USD) | — | — | — | 1.83B | 2.02B | 2.11B | 2.07B | 2.21B | 2.13B | 2.13B |
| Net debt (borrowings + leases - cash) (USD) | 30.7B | 32.3B | 32.3B | 35.5B | 31.9B | 36B | 40B | 41.6B | 44.1B | 48.4B |
| Cash flow detail | ||||||||||
| Operating cash flow (USD) | 5.65B | 5.43B | 6.76B | 7.6B | 9.23B | 8.96B | 8.52B | 9.43B | 10.5B | 12.6B |
| Purchases of property, plant and equipment (USD) | -2.76B | -3.02B | -3.57B | -4.16B | -2.84B | -3.58B | -4.4B | -4.74B | -4.88B | -4.94B |
| Change in receivables (cash effect) (USD) | -3.25B | -4.64B | -423M | -326M | 327M | -962M | -797M | -935M | -799M | -94M |
| Change in payables (cash effect) (USD) | 144M | 374M | 698M | 396M | 1.26B | 999M | -296M | 604M | 359M | 666M |
| Dividends paid (cash effect) (USD) | — | 0.00 | -487M | -550M | -153M | -624M | -653M | -661M | -690M | -679M |
| Share buybacks (cash effect) (USD) | -2.75B | -2.05B | -1.53B | -1.03B | -441M | -8.22B | -7B | -3.81B | -6.04B | -10.1B |
| Interest paid (cash effect) (USD) | -1.67B | -1.7B | -1.74B | -1.91B | -1.61B | -1.5B | -1.66B | -1.89B | -1.94B | -2.21B |
| Income taxes paid (cash effect) (USD) | -1.26B | -1.21B | -872M | -849M | -1B | -2.18B | -1.18B | -1.39B | -1.84B | -1.74B |
| Share-based compensation (USD) | 251M | 270M | 268M | 347M | 362M | 440M | 341M | 262M | 360M | 401M |
| Operating cash flow before change in receivables (USD) | 8.9B | 10.1B | 7.18B | 7.93B | 8.91B | 9.92B | 9.32B | 10.4B | 11.3B | 12.7B |
| Free cash flow (OCF - PPE - intangibles) (USD) | 2.89B | 2.41B | 3.19B | 3.44B | 6.4B | 5.38B | 4.13B | 4.69B | 5.64B | 7.69B |
| Income detail | ||||||||||
| Total comprehensive income (USD) | 3.36B | 2.8B | 4.38B | 4.07B | 4.35B | 7.82B | 6.75B | 6.16B | 6.7B | 7.86B |
| Comprehensive income to owners (USD) | 2.82B | 2.28B | 3.78B | 3.43B | 3.71B | 7.05B | 5.56B | 5.31B | 5.8B | 6.87B |
| Provision for credit losses (USD) | 3.26B | 4.04B | — | — | — | — | — | — | — | — |
| Credit cost ratio (credit losses / average receivables) (%) | 55.6% | 65.5% | — | — | — | — | — | — | — | — |
| Reported | Feb 22, 2017 | Feb 20, 2020 | Feb 21, 2019 | Feb 20, 2020 | Feb 19, 2021 | Feb 18, 2022 | Feb 17, 2023 | Feb 16, 2024 | Feb 14, 2025 | Feb 10, 2026 |
Operating KPIs — quarters
Business figures the company publishes beside its accounts (users, subscribers, same-store sales, production, occupancy ...), read from its results releases and reports, with the growth on the same period a year earlier beneath each: computed from the figures, and as the company states it where it does. Each figure links to its source; counts at a period end show under that period.
Operating KPIs — years
Business figures the company publishes beside its accounts (users, subscribers, same-store sales, production, occupancy ...), read from its results releases and reports, with the growth on the same period a year earlier beneath each: computed from the figures, and as the company states it where it does. Each figure links to its source; counts at a period end show under that period.
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpMaterial events reported to the SEC on Form 8-K or 6-K, newest first. The link opens the filing itself on EDGAR. Press releases from the company's own website, newest first.
November 2, 2026
NASHVILLE, Tenn.--(BUSINESS WIRE)-- HCA Healthcare, Inc. (NYSE: HCA) today announced that its wholly owned subsidiary, HCA Inc., proposes to offer senior notes, subject to market and other considerations. Actual terms of the senior notes, including maturity, interest rate and principal amount, will depend on market conditions at the time of pricing. HCA Inc. intends to use the net proceeds from this offering for general corporate purposes, which may include the redemption of all or a portion of the $1.200 billion outstanding aggregate principal amount of its 4.500% senior notes due February 2027, the repayment of outstanding borrowings under its $8.000 billion commercial paper program and the repayment of any outstanding borrowings under its senior unsecured credit facility.
Mizuho Securities USA LLC, Barclays Capital Inc., BofA Securities, Inc., and Wells Fargo Securities, LLC are acting as the joint book-running managers for the offering.
The offering of the senior notes is being made pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission. The offering is being made only by means of a preliminary prospectus supplement and the accompanying prospectus, copies of which may be obtained by contacting Mizuho Securities USA LLC, Attn: Debt Capital Markets, 1271 Avenue of the Americas, New York, NY 10020, or by calling toll-free at 1-866-271-7403; Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by email at [email protected] or telephone at 1-888-603-5847; BofA Securities, Inc., NC1-022-02-25, 201 North Tryon Street, Charlotte, NC 28255-0001, Attn: Prospectus Department, by email: [email protected] or by telephone: 1-800-294-1322; or Wells Fargo Securities, LLC, 608 2nd Avenue South, Suit 1000, Minneapolis, MN 55402, Attn: WFS Customer Service, by email: [email protected] or by telephone (toll-free): 1-800-645-3751.
You may also visit www.sec.gov to obtain an electronic copy of the related preliminary prospectus supplement and the accompanying prospectus.
This press release does not constitute an offer to sell or a solicitation of an offer to buy the senior notes or any other security or a notice of redemption of any 4.500% senior notes due February 2027 and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which, or to any persons to whom, such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. Any notice of redemption of the 4.500% senior notes due February 2027 will be made pursuant to a separately issued notice of redemption.
**FORWARD-LOOKING STATEMENTS
**Information provided and statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements only speak as of the date of this press release and HCA assumes no obligation to update the information included in this press release. Such forward-looking statements include the expected use of proceeds from the offering. These statements often include words such as “may,” “believe,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “initiative” or “continue.” These forward-looking statements are not historical facts and are based on current expectations, estimates and projections about HCA’s industry, management’s beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond HCA’s control. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees of future performance or occurrence of events and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Although HCA believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. More information about potential risks and uncertainties that could affect the Company’s business and results of operations is included in the “Risk Factors” and “Forward-Looking Statements” sections in the Annual Report on Form 10-K filed by the Company with the SEC on February 10, 2026 and our other filings with the Securities and Exchange Commission. Unless otherwise required by law, HCA also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made in this press release.
All references to the “Company” and “HCA” as used throughout this press release refer to HCA Healthcare, Inc. and its affiliates.
INVESTOR CONTACT:
Frank Morgan
615-344-2688
MEDIA CONTACT:
Harlow Sumerford
615-344-1851
Source: HCA Healthcare
Quick Links
IR Contact
Investor Email Alerts
To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.
At HCA Healthcare, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.
By providing your email address below, you are providing consent to HCA Healthcare to send you the requested Investor Email Alert updates.
* Required
Email Address * Investor Alert Options *
| News |
| Events & Presentations |
| Annual Reports |
| SEC Filings |
| End of Day Stock Quote |
| Enter the code shown above. |
| * |
Submit
Submit
Email Alert Sign Up Confirmation
-
For patients
-
Additional resources
-
Our organization
About HCA Healthcare | Government Relations | Careers | Contact Us | We Show Up
-
Publications
HCA Healthcare Today | HCA Healthcare Magazine | Annual Impact Report

Follow Us
Copyright 1999-2026, C-HCA, Inc; All rights reserved.
California Notice at Collection | Right to Receive Estimate | Terms of Use | Notice of Privacy Practices | Privacy Policy
| Social Media Policy | Acceptable Use Policy | Surprise Billing | Nondiscrimination Notice | Accessibility | Disclosures | Cookie Preferences
October 29, 2026
HCA Healthcare hospitals earned more 2027 specialty care recognitions than any other health system, including national distinctions for surgical care, emergency medicine and orthopedic surgery
NASHVILLE, Tenn.--(BUSINESS WIRE)-- HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that 102 of its hospitals have been recognized by Healthgrades for excellence in specialty care, more than any other health system in the country. The 2027 recognitions reflect clinical outcomes in important areas of patient care, including surgical care, emergency medicine and orthopedic surgery.
For patients and families making healthcare decisions, these recognitions provide information about hospitals that have demonstrated strong clinical outcomes in specific areas of care. Healthgrades evaluates hospitals using measures such as risk-adjusted mortality and complication rates, which account for differences in patients’ health conditions and the complexity of their care.
Among HCA Healthcare hospitals’ 2027 Healthgrades achievements:
- 102 hospitals received specialty care recognition, the most of any health system nationwide.
- 56 hospitals earned the Surgical Care Excellence Award, representing the most recipients of any health system in the country.
- 45 hospitals received the new Emergency Medicine Excellence Award, more than any other health system nationwide. The award recognizes hospitals for clinical outcomes involving serious conditions commonly associated with emergency admissions, including heart attack, stroke and sepsis.
- 52 hospitals were named among America’s 100 Best Hospitals for Orthopedic Surgery, representing more than half of all hospitals receiving this national distinction.
Across the recognized hospitals, HCA Healthcare received 280 America’s Best Specialty distinctions and 617 Specialty Excellence Awards, both the highest totals among health systems nationwide.
“Patients place an extraordinary amount of trust in the people caring for them, often during some of the most difficult moments in their lives,” said Michael Schlosser, M.D., MBA, executive vice president and chief clinical officer of HCA Healthcare. “These awards reflect the expertise, dedication and teamwork of the physicians, nurses and colleagues who care for our patients every day. They also reinforce our responsibility to keep learning, measuring our performance and finding ways to help make care safer and better for every patient we serve.”
HCA Healthcare supports its caregivers through a connected network designed to enable hospitals to share expertise, learn from clinical data and promote practices to improve patient care. For example, drawing on its system-wide experience of approximately 10 million emergency room visits annually, HCA Healthcare works with clinical teams to identify opportunities for improvement and share best practices across its hospitals. In 2025, the organization also standardized technology across its emergency departments to help care teams have a more complete view of patient information, supporting timely clinical decisions and coordinated care.
The Healthgrades specialty care recognitions are based on an analysis of clinical outcomes for common conditions and procedures. The awards recognize performance in specific specialties by evaluating hospitals using objective clinical measures.
While these recognitions highlight strong performance at individual hospitals, HCA Healthcare remains focused on improving clinical outcomes and the care experience across its network. The organization continues to evaluate performance, identify opportunities for improvement and support caregivers in delivering safe, effective and compassionate care.
To learn more about Healthgrades’ methodology, visit https://www.healthgrades.com/quality/ratings-awards/methodology .
About HCA Healthcare
Nashville-based HCA Healthcare is one of the nation’s leading providers of healthcare services comprising 189 hospitals and approximately 2,600 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 19 states and the United Kingdom. With its founding in 1968, HCA Healthcare created a new model for hospital care in the United States, using combined resources to strengthen hospitals, deliver patient-focused care and improve the practice of medicine. HCA Healthcare has conducted a number of clinical studies, including one that demonstrated that full-term delivery is healthier than early elective delivery of babies and another that identified a clinical protocol that can reduce bloodstream infections in ICU patients by 44%. HCA Healthcare is a learning health system that uses its approximately 47 million annual patient encounters to advance science, improve patient care and save lives.
All references to “Company,” “HCA” and “HCA Healthcare” as used throughout this document refer to HCA Healthcare, Inc. and its affiliates.
INVESTOR CONTACT:
Frank Morgan
615-344-2688
MEDIA CONTACT:
Harlow Sumerford
615-344-1851
Source: HCA Healthcare
Quick Links
IR Contact
Investor Email Alerts
To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.
At HCA Healthcare, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.
By providing your email address below, you are providing consent to HCA Healthcare to send you the requested Investor Email Alert updates.
* Required
Email Address * Investor Alert Options *
| News |
| Events & Presentations |
| Annual Reports |
| SEC Filings |
| End of Day Stock Quote |
| Enter the code shown above. |
| * |
Submit
Submit
Email Alert Sign Up Confirmation
-
For patients
-
Additional resources
-
Our organization
About HCA Healthcare | Government Relations | Careers | Contact Us | We Show Up
-
Publications
HCA Healthcare Today | HCA Healthcare Magazine | Annual Impact Report

Follow Us
Copyright 1999-2026, C-HCA, Inc; All rights reserved.
California Notice at Collection | Right to Receive Estimate | Terms of Use | Notice of Privacy Practices | Privacy Policy
| Social Media Policy | Acceptable Use Policy | Surprise Billing | Nondiscrimination Notice | Accessibility | Disclosures | Cookie Preferences
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
Company History
Name and ticker changes, and re-registrations under a new regulatory id. When a ticker stopped being used is not recorded, so former tickers are undated.
| Date | Change | Detail |
|---|---|---|
| May 9, 2017 | Renamed | HCA HOLDINGS, INC. → HCA HEALTHCARE, INC. |
| Jul 2, 2001 | Renamed | HCA THE HEALTHCARE CO → HCA INC/TN |
| Aug 7, 2000 | Renamed | COLUMBIA HCA HEALTHCARE CORP → HCA-THE HEALTHCARE CO |
ETFs Holding HCA Healthcare, Inc.
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| FCTE | 5.01% | 31,363 | $ 12.228M | Jun 30, 2026 |
| YALL | 4.88% | 7,041 | $ 3.603M | Nov 17, 2026 |
| NEWZ | 3.78% | 1,568 | $ 790K | Nov 18, 2026 |
| STNC | 3.17% | 7,315 | $ 2.945M | Jul 31, 2026 |
| JPEF | 2.91% | 112,343 | $ 56.305M | Nov 17, 2026 |
| ABIG | 2.71% | 3,208 | $ 1.61M | Nov 18, 2026 |
| WLTG | 2.06% | 3,942 | $ 1.587M | Jul 31, 2026 |
| CPAI | 1.95% | 18,452 | $ 7.194M | Jun 30, 2026 |
| PRAY | 1.68% | 3,375 | $ 1.316M | Jun 30, 2026 |
| AMID | 1.60% | 3,710 | $ 1.86M | Nov 18, 2026 |
| JDOC | 1.55% | 305 | $ 152.863K | Nov 17, 2026 |
| FEGE | 1.51% | 91,325 | $ 37.85M | Aug 31, 2026 |
| BUSA | 1.25% | 9,586 | $ 3.737M | Jun 30, 2026 |
| CBLS short | -1.12% | -1,546 | $ -622.404K | Jul 31, 2026 |
| JAVA | 1.06% | 157,037 | $ 78.705M | Nov 17, 2026 |
| SURE | 1.05% | 1,206 | $ 604.435K | Nov 17, 2026 |
| ACVU | 1.05% | 5,814 | $ 0.00 | Nov 18, 2026 |
| LCF | 1.04% | 1,725 | $ 672.56K | Jun 30, 2026 |
| TMED | 0.95% | 562 | $ 219.118K | Jun 30, 2026 |
| PSET | 0.88% | 652 | $ 254.208K | Jun 30, 2026 |
| SEIV | 0.86% | 32,392 | $ 12.629M | Jun 30, 2026 |
| AFLG | 0.78% | 14,011 | $ 7.171M | Nov 16, 2026 |
| GDMA | 0.77% | 2,889 | $ 1.45M | Nov 18, 2026 |
| RFFC | 0.72% | 566 | $ 234.579K | Aug 31, 2026 |
| TCAL | 0.71% | 4,566 | $ 2.337M | Nov 17, 2026 |
| LCAP | 0.71% | 33,105 | $ 12.907M | Jun 30, 2026 |
| WTV | 0.66% | 49,671 | $ 19.366M | Jun 30, 2026 |
| MFUT | 0.65% | 951 | $ 486.703K | Nov 17, 2026 |
| VFVA | 0.53% | 12,176 | $ 5.046M | Aug 31, 2026 |
| VFMF | 0.51% | 12,105 | $ 5.017M | Aug 31, 2026 |
| IALT | 0.46% | 71,212 | $ 36.445M | Nov 16, 2026 |
| LSVD | 0.46% | 7,404 | $ 2.981M | Jul 31, 2026 |
| RGLO | 0.45% | 3,896 | $ 1.519M | Jun 30, 2026 |
| CGGR | 0.45% | 219,168 | $ 112.166M | Nov 16, 2026 |
| BTAL | 0.42% | 3,036 | $ 1.184M | Jun 30, 2026 |
| FLDZ | 0.39% | 41 | $ 15.985K | Jun 30, 2026 |
| TVAL | 0.39% | 8,719 | $ 4.462M | Nov 17, 2026 |
| ENHU | 0.37% | 68 | $ 34.801K | Nov 16, 2026 |
| NANC | 0.36% | 1,881 | $ 962.658K | Nov 17, 2026 |
| UPSD | 0.33% | 972 | $ 391.317K | Jul 31, 2026 |
| TFPN | 0.31% | 942 | $ 482.097K | Nov 17, 2026 |
| FLSP | 0.30% | 7,357 | $ 2.868M | Jun 30, 2026 |
| BAMG | 0.28% | 871 | $ 360.986K | Aug 31, 2026 |
| CAPE | 0.28% | 1,717 | $ 669.441K | Jun 30, 2026 |
| CDX | 0.28% | 1,353.863 | $ 678.543K | Nov 17, 2026 |
| SFTY | 0.26% | 5,023 | $ 2.082M | Aug 31, 2026 |
| STOX | 0.26% | 1,422 | $ 589.348K | Aug 31, 2026 |
| VSLU | 0.26% | 3,612 | $ 1.408M | Jun 30, 2026 |
| PEPS | 0.24% | 180 | $ 70.18K | Jun 30, 2026 |
| THRO | 0.24% | 48,615 | $ 24.88M | Nov 16, 2026 |
| LGDX | 0.23% | 605 | $ 309.627K | Nov 17, 2026 |
| MPLY | 0.22% | 87 | $ 35.025K | Jul 31, 2026 |
| DYNF | 0.18% | 142,918 | $ 73.143M | Nov 16, 2026 |
| APUE | 0.17% | 10,399 | $ 4.31M | Aug 31, 2026 |
| XMAG | 0.15% | 636 | $ 318.42K | Nov 13, 2026 |
| SFGV | 0.15% | 3,408 | $ 1.71M | Nov 18, 2026 |
| GDE | 0.14% | 1,629 | $ 675.139K | Aug 31, 2026 |
| NTSX | 0.14% | 4,722 | $ 1.841M | Jun 30, 2026 |
| VOXP | 0.13% | 18 | $ 7,246.62 | Jul 31, 2026 |
| MODL | 0.12% | 3,280 | $ 1.279M | Jun 30, 2026 |
| NTSD | 0.12% | 114 | $ 44.447K | Jun 30, 2026 |
| DFUS | 0.11% | 47,247 | $ 23.655M | Nov 12, 2026 |
| ACIO | 0.11% | 6,205 | $ 2.498M | Jul 31, 2026 |
| ADME | 0.10% | 751 | $ 302.345K | Jul 31, 2026 |
| DCOR | 0.10% | 89,987 | $ 45.053M | Nov 12, 2026 |
| INRO | 0.10% | 1,192 | $ 610.042K | Nov 16, 2026 |
| DFAU | 0.10% | 25,453 | $ 12.743M | Nov 12, 2026 |
| ACVF | 0.09% | 337 | $ 135.673K | Jul 31, 2026 |
| HCMT | 0.08% | 1,081 | $ 435.2K | Jul 31, 2026 |
| TACU | 0.07% | 26 | $ 13.306K | Nov 17, 2026 |
| GEW | 0.07% | 256 | $ 106.099K | Aug 31, 2026 |
| AVSU | 0.07% | 684 | $ 350.058K | Nov 16, 2026 |
| AAUS | 0.07% | 669 | $ 340K | Nov 18, 2026 |
| FELV | 0.07% | 5,732 | $ 2.235M | Jun 30, 2026 |
| MSLC | 0.07% | 6,394 | $ 2.65M | Aug 31, 2026 |
| GSPY | 0.06% | 749 | $ 383.323K | Nov 17, 2026 |
| AVUS | 0.05% | 15,340 | $ 7.851M | Nov 16, 2026 |
| AVLC | 0.05% | 1,556 | $ 796.33K | Nov 16, 2026 |
| CSHP | 0.04% | 313 | $ 160.187K | Nov 16, 2026 |
| DFAC | 0.04% | 63,716 | $ 31.9M | Nov 12, 2026 |
| DUHP | 0.03% | 10,329 | $ 5.171M | Nov 12, 2026 |
| GVLU | 0.02% | 120 | $ 61.414K | Nov 17, 2026 |
| DFSU | 0.02% | 921 | $ 461.108K | Nov 12, 2026 |
| DXUV | 0.00% | 99 | $ 49.565K | Nov 12, 2026 |
| CORO | 0.00% | 93 | $ 47.518K | Nov 16, 2026 |
